参考文献/References:
[1] Feigin VL,Forouzanfar MH,Krishnamurthi R,et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet (London,England),2014,383(9913):245-254.
[2] Krishnamurthi RV,Feigin VL,Forouzanfar MH,et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010[J].Lancet Global Health,2013,1(5):e259-e281.
[3] GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death,1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet (London,England) ,2015,385(9963):117-171.
[4] 蒋雄京,邹玉宝.锁骨下/颅外椎动脉狭窄的处理:中国专家共识[J].中国循环杂志,2019,34(6):523-532.
[5] Liu M,Wu B,Wang WZ,et al. Stroke in China: epidemiology,prevention,and management strategies[J].Lancet Neurol,2007,6(5):456-464.
[6] Marquardt L,Kuker W,Chandratheva A,et al. Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study[J]. Brain,2009,132(Pt4):982-988.
[7] Wityk RJ,Chang HM,Rosengart A,et al. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry[J]. Arch Neurol,1998,55(4):470-478.
[8] Spetzler RF,Hadley MN,Martin NA,et al. Vertebrobasilar insufficiency. Part 1: Microsurgical treatment of extracranial vertebrobasilar disease[J]. J N eurosurg,1987,66(5):648-661.
[9] Aboyans V,Ricco JB,Bartelink MEL,et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases,in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral,mesenteric,renal,upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)[J]. Eur Heart J,2018,39(9):763-816.
[10] 华扬,惠品晶,邢瑛琦.中国脑卒中血管超声检查指导规范[J].中华医学超声杂志(电子版),2015,12(8):599-610.
[11] 杜万良,栾璟煜,王春育,等.美国缺血性卒中及短暂性脑缺血发作患者卒中预防指南[J].中国卒中杂志,2011,6(1):53-86.
[12] Hellmich B,Agueda A,Monti S,et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis[J]. Ann Rheum Dis,2020,79(1):19-30.
[13] 中华医学会风湿病学分会.大动脉炎诊断及治疗指南[J].中华风湿病学杂志,2011,15(2):119-120.
[14] 蒋雄京,张慧敏,吴海英,等. 锁骨下动脉狭窄经皮介入治疗152例分析[J].中华心血管病杂志,2007,35(4):316-319.
[15] Park MC,Lee SW,Park YB,et al. Post-interventional immunosuppressive treatment and vascular restenosis in Takayasus arteritis[J]. Rheumatology (Oxford),2006,45(5):600-605.
[16] Motarjeme A,Keifer JW,Zuska AJ. Percutaneous transluminal angioplasty of the vertebral arteries[J]. Radiology,1981,139(3):715-717.
[17] Higashida RT,Tsai FY,Halbach VV,et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries[J]. J Neurosurg,1993,78(2):192-198.
[18] Cloud GC,Crawley F,Clifton A,et al. Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series[J]. J N eurol N eurosurg Psychiatry,2003,74(5):586-590.
[19] Che WQ,Dong H,Jiang XJ,et al. Clinical outcomes and influencing factors of in-stent restenosis after stenting for symptomatic stenosis of the vertebral V1 segment[J]. J Vasc Surg,2018,68(5):1406-1413.
[20] Storey GS,Marks MP,Dake M,et al. Vertebral artery stenting following percutaneous transluminal angioplasty. Technical note[J]. J Neurosurg,1996,84(5):883-887.
[21] 谷涌泉,高喜翔,郭建明.症状性椎动脉重度狭窄的腔内治疗进展[J].中国医师杂志,2019,21(12):1761-1764.
[22] Tank VH,Ghosh R,Gupta V,et al. Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis[J]. J N eurointerv Surg,2016,8(8):770-774.
[23] Rastan A,McKinsey JF,Garcia LA,et al. One-year outcomes following directional atherectomy of popliteal artery lesions: subgroup analysis of the prospective,multicenter DEFINITIVE LE trial[J]. J Endovasc Ther,2018,25(1):100-108.
[24] 谷涌泉,郭建明,崔世军,等.定向斑块切除联合药物涂层球囊治疗椎动脉重度狭窄1例[J].介入放射学杂志,2018,27(1):17-19.
[25] 苗雨晴,李拥军.药物涂层球囊在外周血管疾病中的应用及展望[J].中国临床医生杂志,2020,48(8):898-900.
[26] Gruber P,Berberat J,Kahles T,et al. Angioplasty using drug-coated balloons in ostial vertebral artery stenosis[J]. Ann Vasc Surg,2020,64:157-162.
[27] 蒋雄京.大动脉炎的诊断和治疗问题[J].医学研究杂志,2008(8),37:6-9.
[28] Tanaka R,Higashi M,Naito H. Angioplasty for non-arteriosclerotic renal artery stenosis: the efficacy of cutting balloon angioplasty versus conventional angioplasty[J]. Cardiovasc Intervent Radiol,2007,30(4):601-606.
[29] Peng M,Ji W,Jiang X,et al. Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis:two-year results[J]. Int J Cardiol,2016,205:117-123.
[30] Hecht T,Esmaeili A,Behnke-Hall K. Balloon angioplasty of the bilateral renal arteries by Takayasu arteritis with a paclitaxel-eluting balloon[J].Cardiol Young,2015,25(7):1431-1434.
[31] Roon AJ,Ehrenfeld WK,Cooke PB,et al. Vertebral artery reconstruction[J]. Am J Surg,1979,138(1):29-36.
[32] Berguer R,Flynn LM,Kline RA,et al. Surgical reconstruction of the extracranial vertebral artery: management and outcome[J].J Vasc Surg,2000,31(1 Pt 1):9-18.
[33] Kieffer E,Praquin B,Chiche L,et al. Distal vertebral artery reconstruction: long-term outcome[J]. J Vasc Surg,2002,36(3):549-554.
[34] 顾沅芮,孙阳雪,田晨,等.锁骨下动脉-颈总动脉转位术在不能介入治疗的锁骨下动脉近端闭塞患者中的应用[J].中国胸心血管外科临床杂志,2020,27(9):1005-1009.
[35] Berguer R,Bauer RB. Vertebral artery reconstruction. A successful technique in selected patients[J]. Ann Surg,1981,193(4):441-447.
[36] 谷涌泉,张成超,齐立行,等.定向斑块切除联合药物涂层球囊治疗同侧锁骨下、椎动脉重度狭窄1例报告[J].中国微创外科杂志,2019,19(5):473-475.